Singapore, Feb. 19 -- Israel-based startup Ibex Medical Analytics has announced continued commercial momentum and expanding global adoption alongside a leadership transition designed to accelerate the company's next phase of growth.

Effective immediately, Yair Heller, formerly Chief Operating Officer, has been appointed Chief Executive Officer, and co-founder Joseph Mossel will lead Ibex's rapidly expanding biopharma division and US clinical growth initiatives.

The company is celebrating a series of significant commercial milestones, including strategically important clinical deployments with two of the largest laboratory networks in Europe, as well as PathGroup and HNL Lab Medicine in the US, as well as significant expansions from exis...